Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
Primary central nervous system lymphoma (PCNSL) constitutes a rare group of extranodal non-Hodgkin's lymphoma (NHL) primarily of B cell origin. It occurs in both immuno-competent and immune-compromised patients. High dose methotrexate (HD-MTX) based chemotherapy is the standard therapy. Chemoth...
Main Authors: | Prathima Prodduturi Md, Philip J Bierman Md |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S7752 |
Similar Items
-
Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
by: Prathima Prodduturi, et al.
Published: (2012-05-01) -
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
by: Holdhoff M, et al.
Published: (2020-08-01) -
Review: Primary CNS lymphoma
by: Uwe Schlegel
Published: (2009-03-01) -
Primary CNS Lymphoma in Seropositive Child
by: S. T. Bandichhode, et al.
Published: (2013-01-01) -
Current and Emerging Pharmacotherapy for Fibromyalgia
by: Roie Tzadok, et al.
Published: (2020-01-01)